1-15 of 15
erythrocyte survival
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT

Brief Report
Courtney D. Fitzhugh, Stefan Cordes, Tiffani Taylor, Wynona Coles, Katherine Roskom, Mary Link, Matthew M. Hsieh, John F. Tisdale
Journal: Blood
Blood (2017) 130 (17): 1946–1948.
https://doi.org/10.1182/blood-2017-03-772392
Published: 2017
Includes: Supplemental data
Journal Articles

At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation

Courtney D. Fitzhugh, MD, Matthew M. Hsieh, MD, Stefan Cordes, MD, Tiffani Taylor, PA, Wynona Coles, MPH, Katherine Roskom, RN, John F. Tisdale, MD
Journal: Blood
Blood (2016) 128 (22): 2483.
https://doi.org/10.1182/blood.V128.22.2483.2483
Published: 2016
Journal Articles

Biochemical Surrogate Markers of Hemolysis Do Not Correlate with Directly Measured Erythrocyte Survival in Sickle Cell Anemia

Charles T. Quinn, MD MS, Eric P. Smith, MD, Shahriar Arbabi, Paramjit Khera, PhD, Christopher J. Lindsell, PhD, Omar Niss, MD, Clinton H Joiner, MD PhD, Robert S. Franco, PhD, Robert M. Cohen, MD
Journal: Blood
Blood (2016) 128 (22): 2484.
https://doi.org/10.1182/blood.V128.22.2484.2484
Published: 2016
Journal Articles

Antigen Density Impacts RBC Survival and Antigen Modulation Following Incompatible RBC Transfusion

Justin Yoo, BS, MS, Connie Maridith Arthur, PhD, Patricia Zerra, MD, Kathryn Girard-Pierce, Jeanne E. Hendrickson, MD, Sean R. Stowell, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2350.
https://doi.org/10.1182/blood.V126.23.2350.2350
Published: 2015
Journal Articles

End-Alveolar Carbon Monoxide As a Measure of Erythrocyte Survival and Hemolytic Severity in Sickle Cell Disease

Caterina P. Minniti, MD, John H. Baird, Dihua Xu, Laurel Mendelsohn, BS, Rehan Saiyed, B.S., Mary Jackson, RN, James Nichols, RN, Daniel Kim-Shapiro, PhD, Yang Xia, MD PhD, Gregory J. Kato, MD
Journal: Blood
Blood (2014) 124 (21): 2696.
https://doi.org/10.1182/blood.V124.21.2696.2696
Published: 2014
Journal Articles

Measurement Of Erythrocyte Survival In Vivo using a Stable Isotope Label In Sickle Cell Anemia

Charles T. Quinn, MD, MS, Paramjit K Khera, PhD, Christopher J Lindsell, Ph.D., Clinton H Joiner, MD, PhD, Robert M Cohen, MD, Robert S. Franco, PhD
Journal: Blood
Blood (2013) 122 (21): 2223.
https://doi.org/10.1182/blood.V122.21.2223.2223
Published: 2013
Journal Articles

Correlation Between Red Blood Cell Survival and Cytochrome P450 1A2 Enzyme Activity

Larry J. Dumont, PhD, MBA, Swaroopa Yerrabothala, MD, Gregory J Tsongalis, PhD, Xiaoyun Fu, Ph.D., James C. Zimring, MD, PhD, John Roback, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3658.
https://doi.org/10.1182/blood.V122.21.3658.3658
Published: 2013
Journal Articles

DMT1-Mutant Erythrocytes Have Shortened Life Span, Accelerated Glycolysis and Increased Oxidative Stress

Zuzana Zidova, MSc, Pavla Pospisilova, MSc, Renata Mojzikova, PhD, Katarina Kapralova, MSc, Dalibor Dolezal, DVM, Vladimir Divoky, PhD, Monika Horvathova, PhD
Journal: Blood
Blood (2013) 122 (21): 957.
https://doi.org/10.1182/blood.V122.21.957.957
Published: 2013
Journal Articles

Molecular Basis of Neocytolysis.

Jihyun Song, M.S., Donghoon Yoon, PhD, Perumal Thiagarajan, MD, Josef T. Prchal, MD
Journal: Blood
Blood (2012) 120 (21): 2093.
https://doi.org/10.1182/blood.V120.21.2093.2093
Published: 2012
Journal Articles

Red Blood Cell Scramblase Activation Is Induced by Phorbol Ester and Prevented by Inhibition of Protein Kinase C

Latorya Arnold Barber, B.S., Mary B Palascak, B.S., Clinton H. Joiner, MD, PhD, Robert S. Franco, PhD
Journal: Blood
Blood (2008) 112 (11): 2494.
https://doi.org/10.1182/blood.V112.11.2494.2494
Published: 2008
Journal Articles

Antibody Formation to S-303-Treated RBCS in the Setting of Chronic RBC Transfusion.

Maureen G. Conlan, MD, Adonis Stassinopoulos, PhD, George Garratty, PhD, David Wages, MD, PhD, Laurence Corash, MD, Lindsey Wood, PhD, Steven R. Sloan, MD, Richard J. Labotka, MD
Journal: Blood
Blood (2004) 104 (11): 382.
https://doi.org/10.1182/blood.V104.11.382.382
Published: 2004
Journal Articles

Sickle Cell Patietns with a High Percentage of HBF-Containing RBC (F Cells) Have Shorter Survival of RBC that Lack HBF.

Robert Suez Franco, Ph.D., Peter Ciraolo, M.S., Mary B. Palascak, B.S., Clinton H. Joiner, M.D., Ph.D., Zahida Yasin, M.D., Donald L. Rucknagel, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3588.
https://doi.org/10.1182/blood.V104.11.3588.3588
Published: 2004
Journal Articles

Biotin-Labeled RBC Survival in Thalassemia and Impact of Treatment.

Sylvia Titi Singer, MD, Nancy E. Olivieri, MD, Nancy Sweeters, PNP, Carmen Rodwell, MD, Christina Oliver, Elliott P. Vichinsky, MD, Frans A. Kuypers, PhD
Journal: Blood
Blood (2004) 104 (11): 3616.
https://doi.org/10.1182/blood.V104.11.3616.3616
Published: 2004
Journal Articles

Erythrocyte survival is promoted by plasma and suppressed by a Bak-derived BH3 peptide that interacts with membrane-associated Bcl-X L

Melanie Walsh, Robert J. Lutz, Thomas G. Cotter, Rosemary O'Connor
Journal: Blood
Blood (2002) 99 (9): 3439–3448.
https://doi.org/10.1182/blood.V99.9.3439
Published: 2002
Journal Articles

The relationship between anemia, fecal stercobilinogen, erythrocyte survival, and globin synthesis in heterozygotes for beta-thalassemia

E Gallo, P Pich, G Ricco, G Saglio, C Camaschella, U Mazza
Journal: Blood
Blood (1975) 46 (5): 693–698.
https://doi.org/10.1182/blood.V46.5.693.693
Published: 1975